MicroRNA as a Therapeutic Target in Cardiac Remodeling

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• MicroRNAs (miRNAs) are small RNA molecules (18-25 nucleotides) involved in gene regulation.
• Dysregulated miRNA expression is implicated in various diseases, particularly heart diseases.
• Myocardial remodeling, a pathological consequence of heart diseases, involves complex cellular changes.

Purpose of the Study:

• To review the critical role of microRNAs in regulating myocardial remodeling.
• To elucidate how miRNAs modulate cardiac hypertrophy, cardiomyocyte injury, fibrosis, angiogenesis, and inflammation.
• To identify miRNA targets that influence cardiac remodeling processes.

Main Methods:

• Literature review of studies investigating microRNA expression and function in cardiac diseases.
• Analysis of mechanisms by which miRNAs regulate key aspects of myocardial remodeling.
• Identification and categorization of miRNA targets within cardiac tissues.

Main Results:

• miRNAs are central regulators of myocardial remodeling, influencing cardiac hypertrophy, cardiomyocyte injury, fibrosis, angiogenesis, and inflammation.
• Aberrant miRNA expression can lead to detrimental effects on cardiac function.
• Specific miRNAs target receptors, signaling molecules, and transcription factors to modulate remodeling.

Conclusions:

• Maintaining balanced miRNA expression is crucial for cardiac functional recovery after injury.
• Understanding miRNA roles and targets offers potential therapeutic strategies for heart diseases.
• miRNAs represent key players in the pathogenesis and potential treatment of myocardial remodeling.